The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

The mutational spectrum of human malignant autosomal recessive osteopetrosis

På svenska

Author

  • C Sobacchi
  • A Frattini
  • P Orchard
  • O Porras
  • I Tezcan
  • M Andolina
  • R Babul-Hirji
  • I Baric
  • N Canham
  • D Chitayat
  • S Dupuis-Girod
  • I Ellis
  • A Etzioni
  • A Fasth
  • A Fisher
  • B Gerritsen
  • V Gulino
  • E Horwitz
  • V Klamroth
  • E Lanino
  • M Mirolo
  • A Musio
  • G Matthijs
  • S Nonomaya
  • LD Notarangelo
  • HD Ochs
  • AS Furga
  • J Valiaho
  • JLK van Hove
  • Mauno Vihinen
  • D Vujic
  • P Vezzoni
  • A Villa
Show all

Summary, in English

Human malignant infantile osteopetrosis (arOP; MIM 259700) is a genetically heterogenous autosomal recessive disorder of bone metabolism, which, if untreated, has a fatal outcome. Our group, as well as others, have recently identified mutations in the ATP6i (TCIRG1) gene, encoding the a3 subunit of the vacuolar proton pump, which mediates the acidification of the bone/osteoclast interface, are responsible for a subset of this condition. By sequencing the ATP6i gene in arOP patients from 44 unrelated families with a worldwide distribution we have now established that ATP6i mutations are responsible for similar to 50% of patients affected by this disease. The vast majority of these mutations (40 out of 42 alleles, including seven deletions, two insertions, 10 nonsense substitutions and 21 mutations in splice sites) are predicted to cause severe abnormalities in the protein product and are likely to represent null alleles. In addition, we have also analysed nine unrelated arOP patients from Costa Rica, where this disease is apparently much more frequent than elsewhere. All nine Costa Rican patients bore either or both of two missense mutations (G405R and R444L) in amino acid residues which are evolutionarily conserved from yeast to humans. The identification of ATP6i gene mutations in two families allowed us for the first time to perform prenatal diagnosis: both fetuses were predicted not to be affected and two healthy babies were born. This study contributes to the determination of genetic heterogeneity of arOP and allows further delineation of the other genetic defects causing this severe condition.

Publishing year

2001

Language

English

Pages

1767-1773

Publication/Series

Human Molecular Genetics

Volume

10

Issue

17

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Medical Genetics

Status

Published

ISBN/ISSN/Other

  • ISSN: 0964-6906